PIAZZA ROCCO GIOVANNI

Role
Associate professor  
Academic disciplines
Blood Diseases (MEDS-09/B)
Scientific-Disciplinary Group:
BLOOD DISEASES, ONCOLOGY AND RHEUMATOLOGY (06/MEDS-09)
Office phone
Room:
  • U08, Floor: 4, Room: 4043
  • U08, Floor: 4, Room: LABORATORIO 4.10

Publications

  • Saettini, F., Guerra, F., Mauri, M., Salter, C., Adam, M., Adams, D., et al. (2025). Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia. JOURNAL OF CLINICAL IMMUNOLOGY, 45(1) [10.1007/s10875-024-01793-8]. Detail

  • Castoldi, G., Mauri, M., D’Aliberti, D., Spinelli, S., Testa, L., Gaverina, F., et al. (2025). Transcriptomic Profile of Human Osteoblast-like Cells Grown on Trabecular Titanium. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 26(8) [10.3390/ijms26083598]. Detail

  • Manghisi, B., Cotilli, G., Fedele, M., Perfetti, P., Terruzzi, E., Verga, L., et al. (2025). Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy. FRONTIERS IN IMMUNOLOGY, 16 [10.3389/fimmu.2025.1563736]. Detail

  • Crippa, V., Fontana, D., Civettini, I., Mologni, L., Piazza, R., Gambacorti Passerini, C., et al. (2024). Integrating mutational profiles and transcriptional data with ASTUTE to elucidate the key molecular functions involved in the pathogenesis of cancer. Intervento presentato a: AACR Annual Meeting 2024 - April 5 - 10, 2024, San Diego, Ca, Usa. Detail

  • Malighetti, F., Villa, M., Sala, E., Geeta, G., Arosio, G., Gemelli, M., et al. (2024). Abstract 987: Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy. Intervento presentato a: American Association for Cancer Research Annual Meeting 2024 - April 5-10, 2024, San Diego, CA [10.1158/1538-7445.am2024-987]. Detail

Research projects

Dissecting the tumor microenvironment Waldenström Macroglobulinemia
Year: 2025
Grantors: THE INTERNATIONAL WALDENSTROM'S MACROGLOBULINEMIA FOUNDATION (IWMF)
Towards new therapeutic approaches for the treatment of SETBP1-driven leukemias - II annualità
Year: 2024
Grantors: FONDAZIONE AIRC
Towards new therapeutic approaches for the treatment of SETBP1-driven leukemias - I annualità
Year: 2023
Grantors: FONDAZIONE AIRC
Characterization of the somatic and germline mutation landscape of Triple Negative Myeloproliferative Neoplasms - V annualità
Year: 2022
Grantors: FONDAZIONE AIRC
HEAL ITALIA HEALTH EXTENDED ALLIANCE FOR INNOVATIVE THERAPIES, ADVANCED LAB-RESEARCH, AND INTEGRATED APPROACHES OF PRECISION MEDICINE - PE0000019-PNRR per la Missione 4, componente 2 - Avviso 341/2022
Year: 2022
Call: Avviso pubblico per la presentazione di Proposte di intervento per la creazione di “Partenariati estesi alle università, ai centri di ricerca, alle aziende per il finanziamento di progetti di ricerca di base” – nell’ambito del Piano Nazionale di Ripresa e
Grantors: MINISTERO DELL'UNIVERSITA' E DELLA RICERCA (MUR)

Awards

Awards

  • Premio Fondazione Bruno Farmaceutici 2014, Fondazione Bruno Farmaceutici, 2014